4.7 Article

Adiponectin levels and genotype: A potential regulator of life span in humans

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/gerona/63.5.447

Keywords

adiponectin; genetics; longevity; metabolic syndrome; cardiovascular disease

Funding

  1. NCRR NIH HHS [M01-RR12248, M01 RR012248] Funding Source: Medline
  2. NIA NIH HHS [R01 AG018728, R01 AG18728, R01 AG018728-05] Funding Source: Medline
  3. NIDDK NIH HHS [P30 DK020541, P60 DK020541, DK 20541] Funding Source: Medline

Ask authors/readers for more resources

Although caloric restriction in numerous models extends life, longevity in humans is suggested to be limited by the increased prevalence of obesity. Adiponectin, a fat-derived peptide, has a protective role against age-related disease, and thus is an excellent candidate gene for longevity. We studied adiponectin levels in centenarians (n = 118), their offspring (n = 228), and unrelated participants <95 (n = 78). Adiponectin levels were significantly greater in participants older than 95 years (p = .01), an effect that was independent of sex and body mass index (BMI). Adiponectin levels in the offspring were higher (following adjustment for age, sex, and BMI) compared to controls (p = .02), suggesting that inherited factors play a role in determining adiponectin levels. Over-representation of two common variants in Adiponectin gene (ADIPOQ) in male long-lived individuals combined with their independent association with elevated plasma adiponectin levels (in men and women) suggests that their presence may promote increased life span through the regulation of adiponectin production and/or secretion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available